Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Therapix Biosciences Ltd (TRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,152
  • Shares Outstanding, K 3,200
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,990 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.79

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.61 +14.10%
on 11/16/17
7.12 -26.12%
on 12/12/17
+0.70 (+15.35%)
since 11/15/17
3-Month
4.26 +23.47%
on 11/14/17
7.12 -26.12%
on 12/12/17
-0.48 (-8.36%)
since 09/15/17
52-Week
4.26 +23.47%
on 11/14/17
10.95 -51.96%
on 03/23/17
-3.72 (-41.43%)
since 03/22/17

Most Recent Stories

More News
Therapix Biosciences Announces Completion of Enrollment of Phase IIa Study at Yale University for Tourette Syndrome Program

Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based therapies, announces the completion of enrollment in its...

TRPX : 5.26 (-1.87%)
Therapix Biosciences Spotlighted in Financial and Trade Media Outlets

Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, has received positive...

TRPX : 5.26 (-1.87%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

PALM BEACH, Florida, November 10, 2017 /PRNewswire/ --

TRPX : 5.26 (-1.87%)
TRVN : 1.65 (+5.77%)
CARA : 12.71 (+0.71%)
COLL : 17.43 (+0.75%)
PRGO : 86.50 (+2.93%)
Research for Advanced Treatments Move in the Right Direction to Combat Opioid Epidemic

According to Additions.com, Opioid addiction rates have skyrocketed over the past two decades, costing millions in health insurance costs and lost productivity in the workforce. According to Fortune magazine,...

TRPX : 5.26 (-1.87%)
TRVN : 1.65 (+5.77%)
CARA : 12.71 (+0.71%)
COLL : 17.43 (+0.75%)
PRGO : 86.50 (+2.93%)
Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids

Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based treatments, executed a non-exclusive material transfer agreement...

TRPX : 5.26 (-1.87%)
Therapix Biosciences Reports Third Quarter 2017 Financial Results and Provides Business Update

Therapix Biosciences Ltd. (Nasdaq: TRPX), a specialty clinical-stage pharmaceutical company specializing in the development of cannabinoid-based treatments, today reported financial results for the three...

TRPX : 5.26 (-1.87%)
CURR : 1.8000 (-12.20%)
Therapix to Present at and Attend Investor Conferences in London

Josh Blacher, Chief Financial Officer of Therapix Biosciences Ltd. (Nasdaq: TRPX) ("Therapix" or the "Company"), a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based...

TRPX : 5.26 (-1.87%)
THXBY : 4.0100 (unch)
Therapix Biosciences Third Quarter 2017 Conference Call and Webcast Scheduled for Thursday, November 9, 2017

Therapix Biosciences Ltd. (NASDAQ: TRPX), a specialty clinical stage pharmaceutical Company specializing in the development of cannabinoid-based drugs, announced today that it will host a conference call...

TRPX : 5.26 (-1.87%)
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer

Therapix Biosciences Ltd. (NASDAQ: TRPX) ("Therapix" or the "Company"), a specialty clinical-stage pharmaceutical company developing cannabinoid-based treatments, has appointed Ascher Shmulewitz, M.D.,...

TRPX : 5.26 (-1.87%)
THXBY : 4.0100 (unch)
Live Investor Conference & Webinar: NASDAQ, NYSE and OTC companies present November 2nd

Company executives share vision, answer questions live at VirtualInvestorConferences.com

TRPX : 5.26 (-1.87%)
OR : 10.84 (-1.54%)
HEB : 0.31 (unch)
DSS : 1.22 (-1.61%)
ACHV : 1.18 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Therapix Biosciences Ltd is a specialty pharmaceutical company. It focuses on developing Cannabinoid technologies in treatment of central nervous system disorders. The company's product pipeline consists of THX-TS01, for the treatment of symptoms related to Tourette Syndrome and THX-ULD01, targeted to...

See More

Key Turning Points

2nd Resistance Point 5.57
1st Resistance Point 5.42
Last Price 5.26
1st Support Level 5.15
2nd Support Level 5.03

See More

52-Week High 10.95
Fibonacci 61.8% 8.39
Fibonacci 50% 7.61
Fibonacci 38.2% 6.82
Last Price 5.26
52-Week Low 4.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.